SMITH STAN purchased 2.1% of their position (25K shares) of MAIA BIOTECHNOLOGY, INC. on the open market
Open‑market purchase worth $37.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/5/2025ACC: 0001127602-25-008327
+50K
Net shares
Net buyer
$37.5K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+25K
Price / share
$1.50
Trade value
$37.50K
% of position
2.1%
3/3/2025
1.18M→1.21M
Total
Net shares
+25K
Net value
$37.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/3/2025 | P · Purchase | +25K | $1.50 | $37.50K | 2.1% | 1.18M | 1.21M |
| Total | +25K | $37.50K | ||||||
Derivative Transactions1
Warrants
Indirect
Converts to
Common Stock
25K shares
Shares
+25K
Strike price
1.85
Held after
25K
Exercisable
—
3/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants Indirect | Common Stock25K shares | 3/3/2025 | P · Purchase | +25K | 1.85 | — | 25K |